F-actin is recognized as a damage-associated molecular patterns (DAMPs) by the immune system [56,57]; therefore, the accelerated degradation of f-actin-stabilizing proteins such as drebrin in response to insufficient f-actin loss may prevent unwanted immune responses in neurological diseases in vivo. The gene discussed is DBN1; the disease is nervous system disorder.